An2 Therapeutics

(NASDAQ) ANTX

Current Price$4.76

Market Cap$172.56M

Since IPO (2022)-69%

5 YearN/A

1 Year+282%

1 Month+30%

An2 Therapeutics Financials at a Glance

Market Cap

$172.56M

Revenue (TTM)

$0.00

Net Income (TTM)

$35.17M

EPS (TTM)

$-1.16

P/E Ratio

-4.12

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$4.76

Volume

268,898.087

Open

$4.78

Price

$4.76

Volume

268,898.087

Open

$4.78

Previous Close

$4.74

Daily Range

$4.61 - $5.03

52-Week Range

$1.00 - $6.91

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$4.76

Volume

268,898.087

Open

$4.78

Previous Close

$4.74

Daily Range

$4.61 - $5.03

52-Week Range

$1.00 - $6.91

ANTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About An2 Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Eric Easom, MBA

Website

www.an2therapeutics.com

Headquarters

Menlo Park, CA 94027, US

ANTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-52%

Return on Capital

-72%

Return on Assets

-57%

Earnings Yield

-24.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$172.56M

Shares Outstanding

35.95M

Volume

268.90K

Avg. Volume

1.42M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$38.11M

EBITDA

$38.11M

Operating Cash Flow

$29.83M

Capital Expenditure

$0.00

Free Cash Flow

$29.83M

Cash & ST Invst.

$58.00M

Total Debt

$0.00

An2 Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$172.56M

N/A

Market Cap/Employee

$7.84M

N/A

Employees

N/A

Net Income

$8.71M

-15.8%

EBITDA

$10.00M

N/A

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$58.00M

-30.6%

Accounts Receivable

$900.00K

+200.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-56.78%

N/A

Return on Invested Capital

-71.59%

N/A

Free Cash Flow

$5.24M

+0.7%

Operating Cash Flow

$5.24M

+0.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$5.72+4.57%

VRCAVerrica Pharmaceuticals Inc.

VRCAVerrica Pharmaceuticals Inc.$6.53-4.32%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.53+1.73%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.44-2.04%

PLURPluri Inc.

PLURPluri Inc.$3.21-4.75%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.63-4.68%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$9.25-3.85%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$11.30+0.05%

POETPoet Technologies

POETPoet Technologies$8.03+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.74-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.14-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$18.36-0.02%

RIGTransocean

RIGTransocean$6.79+0.04%

JOBYJoby Aviation

JOBYJoby Aviation$8.93-0.01%

Questions About ANTX

What is the current price of An2 Therapeutics?

An2 Therapeutics is trading at $4.74 per share.

What is the 52-week range for An2 Therapeutics?

Over the past 52 weeks, An2 Therapeutics has traded between $1.00 and $6.91.

How much debt does An2 Therapeutics have?

As of the most recent reporting period, An2 Therapeutics reported total debt of N/A.

How much cash does An2 Therapeutics have on hand?

An2 Therapeutics reported $19.94M in cash and cash equivalents in its most recent financial results.

What is An2 Therapeutics’s dividend yield?

An2 Therapeutics does not currently have a dividend yield.

An2 Therapeutics

An2 Therapeutics Financials at a Glance

ANTX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About An2 Therapeutics

ANTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

An2 Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ANTX

What is the current price of An2 Therapeutics?

What is the 52-week range for An2 Therapeutics?

How much debt does An2 Therapeutics have?

How much cash does An2 Therapeutics have on hand?

What is An2 Therapeutics’s dividend yield?

Premium Investing Services